Rigel Pharmaceuticals Inc (RIGL) income statement
RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$40.09−1.10 (-2.67%)
Close on Nov 20, 2026Market cap $748.88MP/E 2.5Yield –
Rigel Pharmaceuticals Inc financial ratios
See a number that looks wrong?